Hydrocephalus
(HCP) is a chronic neurological brain disorder caused
by a malfunction of the cerebrospinal fluid (CSF) drainage mechanism
in the brain. The current standard method to treat HCP is a shunt
system. Unfortunately, the shunt system suffers from complications
including mechanical malfunctions, obstructions, infections, blockage,
breakage, overdrainage, and/or underdrainage. Some of these complications
may be attributed to the shunts’ physically large and lengthy
course making them susceptible to external forces, siphoning effects,
and risks of infection. Additionally, intracranial catheters artificially
traverse the brain and drain the ventricle rather than the subarachnoid
space. We report a 3D-printed microelectromechanical system-based
implantable valve to improve HCP treatment. This device provides an
alternative approach targeting restoration of near-natural CSF dynamics
by artificial arachnoid granulations (AGs), natural components for
CSF drainage in the brain. The valve, made of hydrogel, aims to regulate
the CSF flow between the subarachnoid space and the superior sagittal
sinus, in essence, substituting for the obstructed arachnoid granulations.
The valve, operating in a fully passive manner, utilizes the hydrogel
swelling feature to create nonzero cracking pressure, P
T ≈ 47.4 ± 6.8 mmH2O, as well as
minimize reverse flow leakage, Q
O ≈
0.7 μL/min on benchtop experiments. The additional measurements
performed in realistic experimental setups using a fixed sheep brain
also deliver comparable results, P
T ≈
113.0 ± 9.8 mmH2O and Q
O ≈ 3.7 μL/min. In automated loop functional tests, the
valve maintains functionality for a maximum of 1536 cycles with the P
T variance of 44.5 mmH2O < P
T < 61.1 mmH2O and negligible
average reverse flow leakage rates of ∼0.3 μL/min.